BN
Another day, another Brookfield deal
Brookfield Asset Management is back in M&A mode, teaming up with La Caisse to acquire Boralex in a cash deal worth $37.25 per share. That’s a chunky premium and a clear signal that the buyers see more value in Boralex as a private company than as a public market nameplate.
Why this matters to investors
For Boralex holders, this is the part where you grin: cash is cash, and the offer bakes in a 31.8% premium to the March 20 close. For Brookfield investors, the story is a little more classic: the firm is leaning into its usual playbook of buying assets when the market is willing to sell them, then trying to wring out long-term value away from the daily noise machine.
The fine print, minus the boredom
The transaction implies about $9.0 billion in enterprise value, or roughly 13x 2026E consensus EBITDA on a combined basis. Translation: this is not some random nibble at the edges — it’s a meaningful bet on renewable infrastructure, and it shows Brookfield still has plenty of appetite for big, patient capital.
Big picture
If you own BN, this probably doesn’t move the needle like a surprise earnings beat would, but it does reinforce the brand: Brookfield is still the company equivalent of a deal-hungry chess player, always thinking three moves ahead. And if you’re watching the broader renewables space, this is another reminder that strategic buyers are still willing to pay up for scale, cash flow, and a little future optionality.